Late complications following the deployment of drug eluting stents.
Recently, attention has been focused on late complications related to drug eluting stents (DES) [Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-6; McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting stents after discontinuation of platelet therapy. Lancet 364 (2004) 1519-21; Eisenberg MJ. Drug-eluting stents: some bare facts. Lancet 364 (2004) 1466-7, [1-3]. We present two cases with late stent thrombosis (LST) and one case with a stent-related aneurysm. All patients were treated with the paclitaxel coated stent (Taxus-R) which is the most commonly used DES in our department.
Nilsen
Dennis W T
DW
University of Bergen, Stavanger, Norway. Dennis.Nilsen@med.uib.no
Melberg
Tor
T
Larsen
Alf-Inge
AI
Barvik
Ståle
S
Bonarjee
Vernon
V
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D003323:Coronary Aneurysm / Q000209:etiology*; D003328:Coronary Thrombosis / Q000209:etiology*; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents / Q000009:adverse effects*